15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $2.7B | $247M | 71.6% | 17.5% | $378M | — | $716M |
| 2024 | $2.1B | $418M | 69.8% | 14.9% | $305M | — | $953M |
| 2023 | $1.7B | $206M | 68.3% | 13.0% | $70M | — | $704M |
| 2022 | $1.3B | $5M | 61.7% | 2.9% | -$4M | $1.4B | $690M |
| 2021 | $1.1B | $17M | 68.4% | 11.5% | -$180M | $1.3B | $806M |
| 2020 | $904M | $7M | 64.4% | 5.7% | -$45M | $1.1B | $922M |
| 2019 | — | $12M | — | — | -$65M | $888M | $214M |
| 2018 | — | $3M | — | — | -$122M | $592M | $114M |
| 2017 | $464M | -$27M | 59.8% | -1.6% | -$33M | $566M | $273M |
| 2016 | $367M | -$29M | 57.5% | -2.9% | -$6M | $333M | $137M |
| 2015 | $264M | -$74M | 50.5% | -18.5% | -$23M | $172M | $123M |
| 2014 | $231M | -$52M | 55.0% | -3.8% | -$3M | $164M | $151M |
| 2013 | — | -$45M | — | — | -$4M | $114M | — |
| 2012 | — | -$52M | — | — | -$40M | $118M | — |
| 2011 | — | -$46M | — | — | -$37M | $109M | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $762M | $91M | 69.5% | 16.0% | $90M | — | $480M |
| Dec '25 | $784M | $102M | 72.5% | 18.7% | $48M | — | $716M |
| Sep '25 | $706M | $88M | 72.2% | 16.7% | $100M | — | $757M |
| Jun '25 | $649M | $23M | 69.7% | 18.7% | $178M | — | $1.1B |
| Mar '25 | $569M | $35M | 71.9% | 15.6% | $52M | — | $1.3B |
| Dec '24 | $598M | $101M | 72.1% | 18.3% | $94M | — | $953M |
| Sep '24 | $544M | $78M | 69.3% | 16.2% | $82M | — | $903M |
| Jun '24 | $489M | $189M | 67.7% | 11.2% | $64M | — | $821M |
| Mar '24 | $442M | $52M | 69.5% | 12.9% | $66M | — | $751M |
| Dec '23 | $510M | $103M | 70.9% | 20.9% | $16M | — | $704M |
| Sep '23 | $433M | $52M | 67.8% | 12.7% | $36M | — | $685M |
| Jun '23 | $397M | $27M | 66.8% | 7.8% | $28M | $1.4B | $660M |
| Mar '23 | $358M | $24M | 67.2% | 7.7% | -$10M | $1.4B | $636M |
| Dec '22 | $370M | $17M | 58.8% | 6.4% | -$14M | $1.4B | $690M |
| Sep '22 | $341M | -$5M | 55.3% | 0.9% | $26M | $1.4B | $737M |
| Jun '22 | $299M | -$35M | 63.6% | -8.9% | $11M | $1.4B | $724M |
| Mar '22 | $295M | $28M | 71.0% | 12.8% | -$27M | $1.4B | $725M |
| Dec '21 | $308M | $29M | 69.3% | 16.2% | -$57M | $1.3B | $806M |
| Sep '21 | $276M | $13M | 68.5% | 12.2% | -$53M | $1.3B | $871M |
| Jun '21 | $263M | -$25M | 69.4% | 10.0% | -$2M | $1.3B | $869M |
How the market has priced PODD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Insulet Corporation's revenue has grown 24.5% per year, and net income grown 105.2% per year. These are computed facts, not advice.
As of FY2025, Insulet Corporation reported — of total debt against $716M of cash; operating income covered interest expense 8.0×.
In FY2025, gross margin was 71.6%, operating margin 17.5%, and net margin 9.1%.
As of Jun '26, Insulet Corporation traded at a price-to-earnings ratio of about 43.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.